Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GS7.DE Stock Summary
In the News
GS7.DE Financial details
Company Rating
Strong Buy
Market Cap
0
Income
5.21B
Revenue
35.31B
Book val./share
5.04
Cash/share
2.01
Dividend
-
Dividend %
-
Employees
90.1K
Optionable
No
Shortable
Yes
Earnings
-
P/E
13.84
Forward P/E
-
PEG
-8.75
P/S
-
P/B
4.68
P/C
-
P/FCF
-
Quick Ratio
0.18
Current Ratio
0.79
Debt / Equity
1.35
LT Debt / Equity
1.15
-
-
EPS (TTM)
1.33
EPS next Y
-
EPS next Q
-
EPS this Y
-18.99%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
18.4%
Revenue last 5Y
2.48%
Revenue Q/Q
-29.15%
EPS Q/Q
-56.6%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
6%
ROE
34%
ROC
0.1%
Gross Margin
66%
Oper. Margin
16%
Profit Margin
15%
Payout
78%
Shs Outstand
4.07B
Shs Float
4.89B
-
-
-
-
Target Price
-
52W Range
-
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
-
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.253953
-
-
Volatility
0.13%, 0.13%
Prev Close
-
Price
-
Change
-
GS7.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 7.72 | 7.75 | 8.41 | 8.46 | 8.57 | |
Net income per share | 0.55 | 1.02 | 1.31 | 1.58 | 1.28 | |
Operating cash flow per share | 1.77 | 2.12 | 2 | 2.09 | 2 | |
Free cash flow per share | 1.21 | 1.67 | 1.46 | 1.54 | 1.26 | |
Cash per share | 1 | 1 | 1.19 | 1.53 | 1.09 | |
Book value per share | -0.02 | 1.1 | 2.84 | 3.62 | 3.78 | |
Tangible book value per share | -5.07 | -4.86 | -5.77 | -4.87 | -4.85 | |
Share holders equity per share | -0.02 | 1.1 | 2.84 | 3.62 | 3.78 | |
Interest debt per share | 4.56 | 6.75 | 7.82 | 6.95 | 6.27 | |
Market cap | 71.59B | 73.83B | 70.61B | 74.91B | 68.76B | |
Enterprise value | 84.85B | 96.02B | 96.41B | 95.97B | 88.66B | |
P/E ratio | 33.01 | 18.25 | 13.4 | 11.73 | 13.49 | |
Price to sales ratio | 2.37 | 2.4 | 2.09 | 2.2 | 2.02 | |
POCF ratio | 10.35 | 8.77 | 8.8 | 8.87 | 8.65 | |
PFCF ratio | 15.18 | 11.14 | 12.06 | 12.08 | 13.69 | |
P/B Ratio | -1.05K | 16.93 | 6.19 | 5.14 | 4.57 | |
PTB ratio | -1.05K | 16.93 | 6.19 | 5.14 | 4.57 | |
EV to sales | 2.81 | 3.12 | 2.86 | 2.81 | 2.6 | |
Enterprise value over EBITDA | 15.3 | 13.71 | 10.93 | 10.06 | 11.03 | |
EV to operating cash flow | 12.26 | 11.4 | 12.02 | 11.37 | 11.15 | |
EV to free cash flow | 17.99 | 14.49 | 16.46 | 15.47 | 17.66 | |
Earnings yield | 0.03 | 0.05 | 0.07 | 0.09 | 0.07 | |
Free cash flow yield | 0.07 | 0.09 | 0.08 | 0.08 | 0.07 | |
Debt to equity | -251.31 | 5.98 | 2.67 | 1.86 | 1.61 | |
Debt to assets | 0.3 | 0.45 | 0.38 | 0.34 | 0.31 | |
Net debt to EBITDA | 2.39 | 3.17 | 2.93 | 2.21 | 2.48 | |
Current ratio | 0.6 | 0.75 | 0.81 | 0.91 | 0.79 | |
Interest coverage | 4.92 | 6.68 | 7.33 | 8.39 | 7.03 | |
Income quality | 4.52 | 2.32 | 1.73 | 1.47 | 1.81 | |
Dividend Yield | 0.05 | 0.05 | 0.06 | 0.05 | 0.06 | |
Payout ratio | 1.8 | 0.97 | 0.75 | 0.62 | 0.78 | |
Sales general and administrative to revenue | 0.32 | 0.32 | 0.34 | 0.34 | 0.32 | |
Research and developement to revenue | 0.15 | 0.13 | 0.14 | 0.15 | 0.15 | |
Intangibles to total assets | 0.41 | 0.4 | 0.52 | 0.5 | 0.51 | |
Capex to operating cash flow | -0.32 | -0.21 | -0.27 | -0.27 | -0.37 | |
Capex to revenue | -0.07 | -0.06 | -0.06 | -0.07 | -0.09 | |
Capex to depreciation | -1.15 | -0.97 | -0.93 | -0.95 | -1.16 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Graham number | 0.47 | 5.01 | 9.16 | 11.36 | 10.44 | |
ROIC | 0.13 | 0.14 | 0.13 | 0.15 | 0.13 | |
Return on tangible assets | 0.07 | 0.12 | 0.14 | 0.16 | 0.13 | |
Graham Net | -11.82 | -11.99 | -13.35 | -12.52 | -12.69 | |
Working capital | -10.66B | -5.56B | -4.56B | -1.9B | -5B | |
Tangible asset value | -19.81B | -19.32B | -23.16B | -19.61B | -19.29B | |
Net current asset value | -36.99B | -37.47B | -41.84B | -39.38B | -39.09B | |
Invested capital | -251.31 | 5.98 | 2.67 | 1.86 | 1.61 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 3.56B | 3.59B | 3.89B | 4.25B | 10.96B | |
Average inventory | 5.33B | 5.52B | 5.71B | 5.97B | 5.89B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 124.51 | 129.91 | 127.5 | 135.88 | 552.2 | |
Days of inventory on hand | 196.12 | 195.17 | 182.98 | 186.99 | 181.92 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 2.93 | 2.81 | 2.86 | 2.69 | 0.66 | |
Inventory turnover | 1.86 | 1.87 | 1.99 | 1.95 | 2.01 | |
ROE | -31.9 | 0.93 | 0.46 | 0.44 | 0.34 | |
Capex per share | -0.56 | -0.45 | -0.54 | -0.56 | -0.74 |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q2
Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.02 | 2.27 | 2.38 | 2.41 | 2.13 | |
Net income per share | 0.38 | 0.34 | 0.23 | 0.53 | 0.23 | |
Operating cash flow per share | 0.32 | 0.64 | 0.94 | 0.63 | 0.5 | |
Free cash flow per share | 0.16 | 0.32 | 0.78 | 0.48 | 0.37 | |
Cash per share | 0.89 | 0.88 | 1.08 | 3.45 | 2.01 | |
Book value per share | 3.84 | 3.85 | 3.76 | 3.99 | 5.04 | |
Tangible book value per share | -4.54 | -4.76 | -4.81 | -4.57 | 1.65 | |
Share holders equity per share | 3.84 | 3.85 | 3.76 | 3.99 | 5.04 | |
Interest debt per share | 6.41 | 6.44 | 6.08 | 8.27 | 6.86 | |
Market cap | 70.91B | 70.59B | 69.2B | 70.34B | 57.66B | |
Enterprise value | 92.89B | 92.75B | 89.1B | 92.7B | 73.3B | |
P/E ratio | 11.53 | 12.9 | 18.6 | 8.12 | 19.32 | |
Price to sales ratio | 8.76 | 7.78 | 7.26 | 7.19 | 8.32 | |
POCF ratio | 54.88 | 27.55 | 18.37 | 27.67 | 35.26 | |
PFCF ratio | 112.37 | 55.24 | 22.07 | 36.24 | 47.69 | |
P/B Ratio | 4.61 | 4.58 | 4.6 | 4.35 | 3.52 | |
PTB ratio | 4.61 | 4.58 | 4.6 | 4.35 | 3.52 | |
EV to sales | 11.48 | 10.22 | 9.35 | 9.48 | 10.58 | |
Enterprise value over EBITDA | 42.55 | 33.92 | 72.5 | 29.44 | 40.21 | |
EV to operating cash flow | 71.89 | 36.2 | 23.65 | 36.47 | 44.83 | |
EV to free cash flow | 147.21 | 72.57 | 28.42 | 47.76 | 60.63 | |
Earnings yield | 0.02 | 0.02 | 0.01 | 0.03 | 0.01 | |
Free cash flow yield | 0.01 | 0.02 | 0.05 | 0.03 | 0.02 | |
Debt to equity | 1.66 | 1.66 | 1.61 | 2.06 | 1.35 | |
Debt to assets | 0.33 | 0.33 | 0.31 | 0.37 | 0.25 | |
Net debt to EBITDA | 10.07 | 8.1 | 16.19 | 7.1 | 8.58 | |
Current ratio | 0.82 | 0.81 | 0.79 | 1.19 | 1.43 | |
Interest coverage | 7.91 | 8.74 | 3.75 | 11.53 | 5.84 | |
Income quality | 0.93 | 2.19 | 5.03 | 1.41 | 1.95 | |
Dividend Yield | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | |
Payout ratio | 0.75 | 0.7 | 1.02 | 0.44 | 1.55 | |
Sales general and administrative to revenue | 0.33 | 0.29 | 0.34 | 0.29 | 0.3 | |
Research and developement to revenue | 0.15 | 0.16 | 0.15 | 0.12 | 0.18 | |
Intangibles to total assets | 0.52 | 0.52 | 0.51 | 0.46 | 0.19 | |
Capex to operating cash flow | -0.51 | -0.5 | -0.17 | -0.24 | -0.26 | |
Capex to revenue | -0.08 | -0.14 | -0.07 | -0.06 | -0.06 | |
Capex to depreciation | -1 | -1.3 | -1.23 | -0.85 | -0.68 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.76 | 5.44 | 4.43 | 6.93 | 5.1 | |
ROIC | 0.04 | 0.03 | 0.02 | 0.04 | 0.03 | |
Return on tangible assets | 0.04 | 0.04 | 0.02 | 0.04 | 0.01 | |
Graham Net | -12.17 | -12.56 | -12.61 | -12.35 | -17.7 | |
Working capital | -3.82B | -4.16B | -5B | 4.71B | 16.35B | |
Tangible asset value | -18.19B | -19.08B | -19.29B | -18.54B | 5.36B | |
Net current asset value | -37.87B | -38.69B | -39.09B | -38.07B | -12.22B | |
Invested capital | 1.66 | 1.66 | 1.61 | 2.06 | 1.35 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 14.44B | 14.75B | 16.39B | 17.57B | 16.19B | |
Average inventory | 6.27B | 6.29B | 6.01B | 5.89B | 5.33B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 502.75 | 474.45 | 429.31 | 428.71 | 612.38 | |
Days of inventory on hand | 223.06 | 194.52 | 141.43 | 146.41 | 192.9 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0.18 | 0.19 | 0.21 | 0.21 | 0.15 | |
Inventory turnover | 0.4 | 0.46 | 0.64 | 0.61 | 0.47 | |
ROE | 0.1 | 0.09 | 0.06 | 0.13 | 0.05 | |
Capex per share | -0.17 | -0.32 | -0.16 | -0.15 | -0.13 |
GS7.DE Frequently Asked Questions
What is GlaxoSmithKline plc stock symbol ?
GlaxoSmithKline plc is a GB stock and trading under the symbol GS7.DE
What is GlaxoSmithKline plc stock quote today ?
GlaxoSmithKline plc stock price is $- today.
Is GlaxoSmithKline plc stock public?
Yes, GlaxoSmithKline plc is a publicly traded company.